Cite
MLA Citation
C.S. Tam et al.. “EFFECT OF SINGLE‐AGENT IBRUTINIB ON TUMOR DEBULKING AND REDUCTIONS IN TUMOR LYSIS SYNDROME (TLS) RISK IN PATIENTS (PTS) WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL).” Hematological oncology, vol. 35, n.d., pp. 233–234. http://access.bl.uk/ark:/81055/vdc_100047524542.0x000031